{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T22:40:35Z","timestamp":1793745635986,"version":"4.6.1"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82503536"],"award-info":[{"award-number":["82503536"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82425055"],"award-info":[{"award-number":["82425055"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82504685"],"award-info":[{"award-number":["82504685"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Biomaterialia"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.actbio.2026.07.014","type":"journal-article","created":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T06:40:11Z","timestamp":1783752011000},"page":"245-260","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["A small-molecule self-assembled nano-prodrug for enhanced therapy of cancer stem cell-enriched pancreatic ductal adenocarcinoma"],"prefix":"10.1016","volume":"220","author":[{"given":"Fu","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaorong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yihui","family":"Ai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3843-1661","authenticated-orcid":false,"given":"Xiaojie","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bowen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Ping","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.actbio.2026.07.014_bib0001","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.pan.2022.06.005","article-title":"Ecoevolutionary biology of pancreatic ductal adenocarcinoma","volume":"22","author":"Raja Arul","year":"2022","journal-title":"Pancreatol.: Off. J. Int. Assoc. Pancreatol. (IAP) [et al.]"},{"issue":"9","key":"10.1016\/j.actbio.2026.07.014_bib0002","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1001\/jama.2021.13027","article-title":"Pancreatic Cancer: a review","volume":"326","author":"Park","year":"2021","journal-title":"JAMa"},{"issue":"12","key":"10.1016\/j.actbio.2026.07.014_bib0003","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/j.dld.2018.08.008","article-title":"Pancreatic cancer: french clinical practice guidelines for diagnosis, treatment and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, ACHBT, AFC)","volume":"50","author":"Neuzillet","year":"2018","journal-title":"Dig. Liver Dis.: Off. J. Ital. Soc. Gastroenterol. Ital. Assoc. Study Liver."},{"issue":"18","key":"10.1016\/j.actbio.2026.07.014_bib0004","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1056\/NEJMoa1304369","article-title":"Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine","volume":"369","author":"Von Hoff","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.actbio.2026.07.014_bib0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.120043","article-title":"Recent advances and prospects in gemcitabine drug delivery systems","volume":"592","author":"Paroha","year":"2021","journal-title":"Int. J. Pharm."},{"issue":"18","key":"10.1016\/j.actbio.2026.07.014_bib0006","doi-asserted-by":"crossref","first-page":"4504","DOI":"10.3390\/ijms20184504","article-title":"Chemoresistance in pancreatic cancer","volume":"20","author":"Zeng","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.actbio.2026.07.014_bib0007","first-page":"375","article-title":"Multidisciplinary standards of care and recent progress in pancreatic ductal adenocarcinoma","volume":"70","author":"Grossberg","year":"2020","journal-title":"CA Cancer J. Clin."},{"issue":"8","key":"10.1016\/j.actbio.2026.07.014_bib0008","doi-asserted-by":"crossref","first-page":"7030","DOI":"10.3390\/ijms24087030","article-title":"Cancer stem cells in pancreatic ductal adenocarcinoma","volume":"24","author":"Bubin","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.actbio.2026.07.014_bib0009","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/bs.acr.2023.02.007","article-title":"Tumor microenvironment interactions with cancer stem cells in pancreatic ductal adenocarcinoma","volume":"159","author":"Palma","year":"2023","journal-title":"Adv. Cancer Res."},{"issue":"8","key":"10.1016\/j.actbio.2026.07.014_bib0010","doi-asserted-by":"crossref","first-page":"926","DOI":"10.3390\/cells8080926","article-title":"Cancer stem cells and targeting strategies","volume":"8","author":"Barbato","year":"2019","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.actbio.2026.07.014_bib0011","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.tips.2023.11.006","article-title":"Biomarkers and targeted therapy for cancer stem cells","volume":"45","author":"Liu","year":"2024","journal-title":"Trends Pharmacol. Sci."},{"issue":"23","key":"10.1016\/j.actbio.2026.07.014_bib0012","doi-asserted-by":"crossref","first-page":"23262","DOI":"10.1021\/acsnano.3c07828","article-title":"Sniping cancer stem cells with nanomaterials","volume":"17","author":"Wang","year":"2023","journal-title":"ACS. Nano."},{"issue":"2","key":"10.1016\/j.actbio.2026.07.014_bib0013","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/fcp.12521","article-title":"Cancer stem cells as therapeutic targets of pancreatic cancer","volume":"34","author":"Razi","year":"2020","journal-title":"Fundam. Clin. Pharmacol."},{"issue":"8","key":"10.1016\/j.actbio.2026.07.014_bib0014","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1111\/cas.14504","article-title":"Targeting of cancer stem cells by differentiation therapy","volume":"111","author":"Arima","year":"2020","journal-title":"Cancer Sci."},{"key":"10.1016\/j.actbio.2026.07.014_bib0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113451","article-title":"Overview of all-trans-retinoic acid (ATRA) and its analogues: structures, activities, and mechanisms in acute promyelocytic leukaemia","volume":"220","author":"Liang","year":"2021","journal-title":"Eur. J. Med. Chem."},{"issue":"4","key":"10.1016\/j.actbio.2026.07.014_bib0016","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/1751-2980.12122","article-title":"Differentiation therapy for solid tumors","volume":"15","author":"Xu","year":"2014","journal-title":"J. Dig. Dis."},{"key":"10.1016\/j.actbio.2026.07.014_bib0017","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2019.116781","article-title":"Cancer stem cell (CSC) resistance drivers","volume":"234","author":"Najafi","year":"2019","journal-title":"Life Sci."},{"issue":"4","key":"10.1016\/j.actbio.2026.07.014_bib0018","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/s41580-020-00324-8","article-title":"Ferroptosis: mechanisms, biology and role in disease","volume":"22","author":"Jiang","year":"2021","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"17","key":"10.1016\/j.actbio.2026.07.014_bib0019","doi-asserted-by":"crossref","first-page":"2726","DOI":"10.3390\/cells11172726","article-title":"Molecular mechanisms of ferroptosis and relevance to cardiovascular disease","volume":"11","author":"Xie","year":"2022","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.actbio.2026.07.014_bib0020","doi-asserted-by":"crossref","first-page":"449","DOI":"10.3390\/ijms24010449","article-title":"Lipid peroxidation and iron metabolism: two corner stones in the homeostasis control of ferroptosis","volume":"24","author":"Rochette","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"11","key":"10.1016\/j.actbio.2026.07.014_bib0021","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.3390\/cells10112981","article-title":"Ferroptosis: cancer stem cells rely on iron until \"to die for\" it","volume":"10","author":"Cosialls","year":"2021","journal-title":"Cells"},{"issue":"2","key":"10.1016\/j.actbio.2026.07.014_bib0022","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1021\/acsnano.1c08664","article-title":"Multienzyme-like reactivity cooperatively impairs glutathione peroxidase 4 and ferroptosis suppressor protein 1 pathways in triple-negative breast cancer for sensitized ferroptosis therapy","volume":"16","author":"Li","year":"2022","journal-title":"ACS. Nano."},{"issue":"1","key":"10.1016\/j.actbio.2026.07.014_bib0023","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/s41565-020-00793-0","article-title":"A nanotherapeutic strategy to overcome chemotherapeutic resistance of cancer stem-like cells","volume":"16","author":"Shen","year":"2021","journal-title":"Nat. Nanotechnol."},{"issue":"2","key":"10.1016\/j.actbio.2026.07.014_bib0024","doi-asserted-by":"crossref","first-page":"C540","DOI":"10.1152\/ajpcell.00331.2022","article-title":"Barriers and opportunities for gemcitabine in pancreatic cancer therapy","volume":"324","author":"Beutel","year":"2023","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.actbio.2026.07.014_bib0025","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.3389\/fphar.2018.01371","article-title":"RSL3 Drives ferroptosis through GPX4 inactivation and ROS production in colorectal cancer","volume":"9","author":"Sui","year":"2018","journal-title":"Front. Pharmacol."},{"issue":"15","key":"10.1016\/j.actbio.2026.07.014_bib0026","doi-asserted-by":"crossref","first-page":"4239","DOI":"10.1039\/D2SC01003H","article-title":"Stimulus-responsive self-assembled prodrugs in cancer therapy","volume":"13","author":"Dong","year":"2022","journal-title":"Chem. Sci."},{"key":"10.1016\/j.actbio.2026.07.014_bib0027","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.jconrel.2020.07.010","article-title":"Controlled drug delivery with nanoassemblies of redox-responsive prodrug and polyprodrug amphiphiles","volume":"326","author":"Deng","year":"2020","journal-title":"J. Control Release"},{"issue":"1","key":"10.1016\/j.actbio.2026.07.014_bib0028","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1080\/10717544.2019.1588424","article-title":"Application and design of esterase-responsive nanoparticles for cancer therapy","volume":"26","author":"Dong","year":"2019","journal-title":"Drug. Deliv."},{"issue":"sup1","key":"10.1016\/j.actbio.2026.07.014_bib0029","doi-asserted-by":"crossref","first-page":"S71","DOI":"10.1080\/10408398.2018.1509201","article-title":"The success and the challenge of all-trans retinoic acid in the treatment of cancer","volume":"59","author":"Ni","year":"2019","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"10.1016\/j.actbio.2026.07.014_bib0030","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.jconrel.2024.02.037","article-title":"Smart exosomes enhance PDAC targeted therapy","volume":"368","author":"Creeden","year":"2024","journal-title":"J. Control Release"},{"issue":"8","key":"10.1016\/j.actbio.2026.07.014_bib0031","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1016\/j.drudis.2021.05.010","article-title":"Stimulus-responsive liposomes for biomedical applications","volume":"26","author":"Antoniou","year":"2021","journal-title":"Drug Discov. Today"},{"issue":"2","key":"10.1016\/j.actbio.2026.07.014_bib0032","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/j.tiv.2013.01.016","article-title":"Dichloro-dihydro-fluorescein diacetate (DCFH-DA) assay: a quantitative method for oxidative stress assessment of nanoparticle-treated cells","volume":"27","author":"Aranda","year":"2013","journal-title":"Toxicol. Vitro: Int. J. Publ. Assoc. BIBRA"},{"issue":"4","key":"10.1016\/j.actbio.2026.07.014_bib0033","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/S0891-5849(02)00848-1","article-title":"C11-BODIPY(581\/591), an oxidation-sensitive fluorescent lipid peroxidation probe: (micro)spectroscopic characterization and validation of methodology","volume":"33","author":"Drummen","year":"2002","journal-title":"Free Radic. Biol. Med."},{"issue":"9","key":"10.1016\/j.actbio.2026.07.014_bib0034","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1038\/s41590-021-00993-3","article-title":"Glutathione peroxidase 4-regulated neutrophil ferroptosis induces systemic autoimmunity","volume":"22","author":"Li","year":"2021","journal-title":"Nat. Immunol."},{"issue":"12","key":"10.1016\/j.actbio.2026.07.014_bib0035","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/j.tcb.2023.07.003","article-title":"The ubiquitin-proteasome system links NADPH metabolism to ferroptosis","volume":"33","author":"Yang","year":"2023","journal-title":"Trends Cell. Biol."},{"issue":"7","key":"10.1016\/j.actbio.2026.07.014_bib0036","doi-asserted-by":"crossref","first-page":"3167","DOI":"10.7150\/thno.52028","article-title":"Holo-lactoferrin: the link between ferroptosis and radiotherapy in triple-negative breast cancer","volume":"11","author":"Zhang","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.actbio.2026.07.014_bib0037","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.freeradbiomed.2020.02.027","article-title":"Lipid peroxidation and ferroptosis: the role of GSH and GPx4","volume":"152","author":"Ursini","year":"2020","journal-title":"Free Radic. Biol. Med."},{"issue":"3","key":"10.1016\/j.actbio.2026.07.014_bib0038","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1124\/pr.58.3.10","article-title":"Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies","volume":"58","author":"Chou","year":"2006","journal-title":"Pharmacol. Rev."},{"issue":"2","key":"10.1016\/j.actbio.2026.07.014_bib0039","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1080\/1061186X.2018.1473409","article-title":"cRGD functionalised nanocarriers for targeted delivery of bioactives","volume":"27","author":"Gajbhiye","year":"2019","journal-title":"J. Drug Target."},{"issue":"7","key":"10.1016\/j.actbio.2026.07.014_bib0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2024.104014","article-title":"Enzyme-responsive liposomes for controlled drug release","volume":"29","author":"Wei","year":"2024","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.actbio.2026.07.014_bib0041","article-title":"Modulatory effects of cancer stem cell-derived extracellular vesicles on the tumor immune microenvironment","volume":"15","author":"Li","year":"2024","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.actbio.2026.07.014_bib0042","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s13045-020-0845-z","article-title":"CD73 sustained cancer-stem-cell traits by promoting SOX9 expression and stability in hepatocellular carcinoma","volume":"13","author":"Ma","year":"2020","journal-title":"J. Hematol. Oncol."},{"issue":"5","key":"10.1016\/j.actbio.2026.07.014_bib0043","doi-asserted-by":"crossref","first-page":"375","DOI":"10.2174\/1574888X13666180810120012","article-title":"ALDH as a stem cell marker in solid tumors","volume":"14","author":"Toledo-Guzm\u00e1n","year":"2019","journal-title":"Curr. Stem. Cell Res. Ther."},{"key":"10.1016\/j.actbio.2026.07.014_bib0044","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.cbi.2014.12.008","article-title":"N,N-diethylaminobenzaldehyde (DEAB) as a substrate and mechanism-based inhibitor for human ALDH isoenzymes","volume":"234","author":"Morgan","year":"2015","journal-title":"Chem. Biol. Interact."},{"issue":"1","key":"10.1016\/j.actbio.2026.07.014_bib0045","doi-asserted-by":"crossref","first-page":"3580","DOI":"10.1038\/s41467-024-47680-z","article-title":"The pRb\/RBL2-E2F1\/4-GCN5 axis regulates cancer stem cell formation and G0 phase entry\/exit by paracrine mechanisms","volume":"15","author":"Chang","year":"2024","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.actbio.2026.07.014_bib0046","first-page":"469","article-title":"Cancer stem cells and hypoxia-inducible factors (Review)","volume":"53","author":"Tong","year":"2018","journal-title":"Int. J. Oncol."},{"issue":"5858","key":"10.1016\/j.actbio.2026.07.014_bib0047","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1126\/science.1151526","article-title":"Induced pluripotent stem cell lines derived from human somatic cells","volume":"318","author":"Yu","year":"2007","journal-title":"Science"},{"issue":"8","key":"10.1016\/j.actbio.2026.07.014_bib0048","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/s41575-020-0300-1","article-title":"Pancreatic cancer stroma: an update on therapeutic targeting strategies","volume":"17","author":"Hosein","year":"2020","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"12","key":"10.1016\/j.actbio.2026.07.014_bib0049","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1200\/JCO.2004.10.142","article-title":"Phase I trial and pharmacokinetics of gemcitabine in children with advanced solid tumors","volume":"22","author":"Reid","year":"2004","journal-title":"J. Clin. Oncol.: Off. J. Am. Soc. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.actbio.2026.07.014_bib0050","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s10928-006-9010-8","article-title":"Model-based drug development: the road to quantitative pharmacology","volume":"33","author":"Zhang","year":"2006","journal-title":"J. Pharmacokinet. Pharmacodyn."},{"key":"10.1016\/j.actbio.2026.07.014_bib0051","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.114127","article-title":"Pharmacokinetics of gemcitabine and its amino acid ester prodrug following intravenous and oral administrations in mice","volume":"180","author":"Thompson","year":"2020","journal-title":"Biochem. Pharmacol."},{"issue":"30","key":"10.1016\/j.actbio.2026.07.014_bib0052","doi-asserted-by":"crossref","first-page":"17480","DOI":"10.1039\/D5NR02005K","article-title":"Recent progress in gemcitabine-loaded nanoparticles for pancreatic cancer therapy: a review","volume":"17","author":"Li","year":"2025","journal-title":"Nanoscale"},{"key":"10.1016\/j.actbio.2026.07.014_bib0053","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/978-1-0716-2651-1_16","article-title":"Protocol for indocyanine green angiography","volume":"2560","author":"Baddam","year":"2023","journal-title":"Methods Mol. Biol."},{"issue":"6","key":"10.1016\/j.actbio.2026.07.014_bib0054","doi-asserted-by":"crossref","DOI":"10.1001\/jamasurg.2019.0484","article-title":"Identification and validation of a biomarker signature in patients with resectable pancreatic cancer via genome-wide screening for functional genetic variants","volume":"154","author":"Dimitrakopoulos","year":"2019","journal-title":"JAMa Surg."},{"key":"10.1016\/j.actbio.2026.07.014_bib0055","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/978-1-59745-280-9_10","article-title":"Identification of human pancreatic cancer stem cells","volume":"568","author":"Li","year":"2009","journal-title":"Methods Mol. Biol."},{"issue":"7","key":"10.1016\/j.actbio.2026.07.014_bib0056","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.3390\/ijms17071025","article-title":"CD133 Modulate HIF-1\u03b1 expression under hypoxia in EMT phenotype pancreatic cancer stem-like cells","volume":"17","author":"Maeda","year":"2016","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.actbio.2026.07.014_bib0057","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.stem.2007.06.002","article-title":"Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer","volume":"1","author":"Hermann","year":"2007","journal-title":"Cell. Stem. Cell."}],"container-title":["Acta Biomaterialia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1742706126004514?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1742706126004514?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T20:00:35Z","timestamp":1786132835000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1742706126004514"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":57,"alternative-id":["S1742706126004514"],"URL":"https:\/\/doi.org\/10.1016\/j.actbio.2026.07.014","relation":{},"ISSN":["1742-7061"],"issn-type":[{"value":"1742-7061","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A small-molecule self-assembled nano-prodrug for enhanced therapy of cancer stem cell-enriched pancreatic ductal adenocarcinoma","name":"articletitle","label":"Article Title"},{"value":"Acta Biomaterialia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.actbio.2026.07.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Acta Materialia Inc. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}